David A. Spellman - 16 May 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, CFO and Treasurer
Signature
/s/ Carolyn Rucci, attorney-in-fact for David A. Spellman
Issuer symbol
AKBA
Transactions as of
16 May 2023
Net transactions value
-$67,890
Form type
4
Filing time
18 May 2023, 18:19:49 UTC
Previous filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $67,890 -63,567 -12% $1.07 446,483 16 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on June 8, 2022.